Triptorelin serves as a synthetic gonadotropin-releasing hormone agonist that regulates hormone levels for research into conditions like prostate cancer and endometriosis. It initially stimulates then desensitizes the pituitary gland, reducing LH, FSH, testosterone, and estrogen. Studies highlight…
# Triptorelin: Synthetic GnRH Agonist for Hormone Research
A Phase III study of a 6-month formulation of triptorelin at 22.5 mg suppressed pre-pubertal luteinizing hormone levels in over 93% of patients at 6 months, rising to nearly 98% at 12 months. This demonstrates its potential in pediatric endocrinology for central precocious puberty. Researchers value its ability to control hormone secretion through pituitary desensitization.
Triptorelin is a synthetic hormone from the gonadotropin-releasing hormone agonist class. Medical applications focus on adjusting hormone levels in the body. It decreases production of hormones like testosterone in men and estrogen in women to address hormone-sensitive disorders.
Triptorelin functions as a gonadotropin-releasing hormone agonist. Initially, it prompts the pituitary gland to release luteinizing hormone and follicle-stimulating hormone. Continued administration desensitizes the gland, causing LH and FSH levels to fall.
The sequence of triptorelin is H-Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2. Its molecular formula stands at C64H82N18O13. The molecular weight measures 1311.4 g/mol, with PubChem CID: 25074470.
For researchers handling peptides, consult the Peptide Glossary /tools/peptide-glossary for detailed terms. Tools like the Half-Life Calculator /tools/peptide-half-life-plotter can assist in studying its duration in plasma.
As a synthetic analogue of gonadorelin, triptorelin features one amino acid change: glycine at position 6 swapped for D-tryptophan. This boosts its agonistic activity and extends plasma half-life. It replicates GnRH's role in controlling LH and FSH release, plus testosterone and estrogen levels 1 .
In premenopausal women with hormone-sensitive breast cancer, it curbs ovarian activity and estrogen, possibly lowering recurrence when paired with chemotherapy. Research indicates it supports fertility preservation, with patients often resuming menstruation and conceiving 3 .
Pairing with exemestane sharply drops estrogen, though BMI can affect results in some cases 4 . A phase 3 trial showed better ovarian recovery but no major changes in pregnancy rates or disease-free survival 5 . More studies seek to verify long-term outcomes.
In children with central precocious puberty, it blocks GnRH to postpone early development. The mentioned Phase III trial on the 22.5 mg 6-month version proved safe, with no unexpected issues 9 .
It regulates the hypothalamus-pituitary-gonadal axis vital for female health. One study assessed effects in healthy women, those with polycystic ovary syndrome, and hypothalamic amenorrhea cases. Findings suggest it aids reproduction, restarts ovulation in PCOS, and enhances GnRH pulsatility in hypothalamic amenorrhea 10 .
Current investigations examine its use for uterine fibroids. Experiments test its hormone control for therapeutic gains in these cases. This could widen its medical applications.
Researchers may use the Dosage & Cycle Planner /tools/peptide-dosage-planner for protocol design. Browse compounds at our catalog /catalog for related options.
Typical reactions include pain or redness at injection sites, headaches, nausea, stomach discomfort, fatigue, dizziness, mood shifts, hot flashes, or reduced libido. Rarer issues involve hypertension, pelvic pain, or ovarian hyperstimulation syndrome.
Weight gain occurs in some due to hormonal effects on metabolism and fat storage. Effects differ by person. Professionals should oversee use for safety.
Triptorelin offers precise hormone regulation in research settings. Its established role in cancer, endometriosis, and puberty studies underscores reliability. Future work may expand its scope while confirming safety.
Peptides referenced: Gonadorelin, Triptorelin.
Related reading: Key Blood Tests for Metabolic Health Monitoring, HPLC Testing for Peptides: Complete Guide to Purity Checks, Top Research Peptides for Metabolic Fat Loss Studies in 2026, Pharmaceutical Peptides: Growth, Challenges, and Key Methods.